Beckman Coulter Life Sciences Acquires Microbioreactor Manufacturer m2p-labs
pixabay.com/Unsplash
“Innovation defines our future,” said Greg Milosevich, President, Beckman Coulter Life Sciences. “m2p-labs core product line complements our existing cell health, liquid handling and laboratory automation business. Our collective team has the opportunity to enhance time-saving solutions for cell line development and process development workflows.”
“m2p-labs and Beckman Coulter Life Sciences share a common vision of accelerating answers, enabling the faster discovery and development of life-changing advances in medicine,” said, Matthias Eggers, Managing Director, m2p-labs. “We are excited to join, and expand, a powerful team to provide invaluable resources to biologics customers around the world.”
m2p-labs was supported in several financings rounds by FIDURA Private Equity Funds and High-Tech Gründerfonds. “It was a privilege for us to work with management on growing m2p-labs to a leading microbioreactor vendor with global reach,” said Klaus Ragotzky, Managing Director and Chairman of the Advisory Board, FIDURA.
m2p-labs associates and products will transition into Beckman Coulter Life Sciences’ Biotechnology Business Unit. The company’s existing Baesweiler, Germany site will remain operational.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.